The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monday Deal Review: August 24, 2009

B&W_BigNickelThis week saw a few headline deals that we covered at the time, including the Vasogen-Cervus-IntelliPharmaCeutics deal, the move by Takeda Canada to take back ACTOS rights from Lilly, and the Lonza offer for Patheon, but other than that it seems like it was a quiet week everywhere. Still, check out some good stuff

ConjuChem Shareholder Approval:

Even though the stock price dropped  following the original announcement of the deal between ConjuChem Biotechnologies Inc. (TSX: CJB) and Colabor Income Fund (TSX : CLB.UN), ConjuChem shareholders approved the Plan of Arrangement this week, which will result in ConjuChem transferring its assets and liabilities (plus $5 million from Colabor in non-dilutive capital) to a Newco while Colabor takes over the resulting ConjuChem shell.

Commercial Deals:

Hot on the heals of a partnership with Genopole® biopark in France, Medicago Inc. (TSXV: MDG), which makes VLP-based influenza vaccines and recently received funding from the Québec Consortium for Drug Discovery, has signed an MOU with Indian pharmaceutical company Ajanta Pharma Limited to commercialize Medicago’s pandemic and seasonal flu vaccines in India and other territories. A formalized agreement and deal structure should be ready within 90 days.

Angiotech Pharmaceuticals Inc. (NASDAQ: ANPI; TSX: ANP) announced the U.S. commercial launch of the Option™ Inferior Vena Cava Filter for the treatment and prevention of pulmonary embolism. Angiotech holds the exclusive worldwide marketing and distribution rights to the product through a licensing agreement with the developer Rex Medical, LP.

MedMira Merrily Goes Around:

MedMira Inc., (NASDAQ: MMIRF, TSX-V: MIR) announced another $150,000 draw-down of their equity line.

Thanks this week to Jacob Cawker for assistance with the Deal Review!

Bookmark and Share

About these ads

One response to “Monday Deal Review: August 24, 2009

  1. Pingback: Monday Deal Review: August 31, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers